JP Morgan Private Wealth Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-40,000	Closed	-$14K	–	1647
2018 Q2	$14K	Hold	40,000	–	–	﹤0.01%	1456
2018 Q1	$60K	Hold	40,000	–	–	﹤0.01%	1251
2017 Q4	$57K	Sell	40,000 -20,000	-33%	-$32.8K	﹤0.01%	1262
2017 Q3	$137K	Hold	60,000	–	–	﹤0.01%	1184
2017 Q2	$81K	Hold	60,000	–	–	﹤0.01%	1195
2017 Q1	$128K	Buy	60,000 +40,000	+200%	+$150K	﹤0.01%	1286
2016 Q4	$88K	Hold	20,000	–	–	﹤0.01%	1211
2016 Q3	$97K	Buy	+20,000	New	+$91.2K	﹤0.01%	1183

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

JP Morgan Private Wealth Advisors's ARLZ Position: Q3 2018 in Review

JP Morgan Private Wealth Advisors sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 40,000 shares — an estimated $14K sold.

JP Morgan Private Wealth Advisors first reported a position in ARLZ in Q3 2016 and held it in 8 quarters. The position peaked at $137K in Q3 2017. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

JP Morgan Private Wealth Advisors reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 40,000 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $14K.
JP Morgan Private Wealth Advisors first reported a position in Aralez Pharmaceuticals Inc. in Q3 2016 and held it in 8 quarters.
JP Morgan Private Wealth Advisors's Aralez Pharmaceuticals Inc. position peaked at $137K in Q3 2017.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.